Minireviews
Copyright ©The Author(s) 2022.
World J Exp Med. May 20, 2022; 12(3): 36-43
Published online May 20, 2022. doi: 10.5493/wjem.v12.i3.36
Table 1 Selected series of stereotactic irradiation for management of pilocytic astrocytoma in pediatric and adult patients
Ref.
Publication year and study period
Histology
Number of patients
Age (yr)
Setting
Treatment
Tumor size
Dose
Prior RT
Follow-up duration
PFS / tumor control
Murphy et al[42]2019 (1990-2016)PA141Median age 14 yr (range: 2-84 yr)As part of initial management or salvage therapyGKSRS Median 3.45 ccMedian margin dose 16 Gy21 patientsMedian 67.3 mo PFS 74.0% at 5 yr; PFS 69.7% at 10 yr
Trifiletti et al[43]2017 (1990-2015)PA28Median age 17.4 yr (range: 2-70.3 yr)As part of initial management or salvage therapyGK-based SRS or SRTMedian 1.84 ccMedian margin dose 16 Gy for single fraction SRS, and 15 Gy delivered in 3 fractions for SRT4 patientsMedian 5.4 yrPFS 96% at 6 yr; Tumor control 93%
Simonova et al[44]2016 (1992-2002)PA25Median age 13 yr (range: 3-17 yr)As part of initial management or salvage therapyGK-based SRS or SRTMedian 2.7 ccMedian margin dose 16 Gy for patients receiving single fraction, median dose 25 Gy delivered in 5 fractions for SRT 2 patientsMedian 15 yrPFS 80% at 10 yr
Lizarraga et al[45]2012 (1995-2010)PA12Median age 21 yr (range: 5-41 yr)Salvage therapyLINAC-based SRS or SRTMedian 6.5 cc for SRT; Median 1.69 cc for SRSMedian dose 18.75 Gy for SRS and median dose 50.4 Gy delivered in 28 fractions for SRT 0 patientsMedian 37.5 moPFS 73.3% at long term
Hallemeier et al[46]2012 (1992-2005)PA18Median age 23 yr (range: 4-56 yr)As part of initial management or salvage therapyGKSRSMedian 9.1 ccMedian margin dose 15 Gy10 patientsMedian 8 yrPFS 41% at 5 yr; Tumor control 75%
Kano et al[47]2009 (1987-2006)PA50Median age 10.5 yr (range: 4.2-17.9 yr)As part of initial management or salvage therapyGKSRSMedian 2.1 ccMedian margin dose 14.5 Gy5 patientsMedian 55.5 moPFS 70.8% at 5 yr
Kano et al[48]2009 (1994-2006)PA14Median age 32 yr (range: 19-52 yr)As part of initial management or salvage therapyGKSRSMedian 4.7 ccMedian margin dose 13.3 Gy6 patientsMedian 36.3 moPFS 31.5% at 5 yr
Hadjipanayis et al[49]2002(1987-2000)PA37Median age 14 yr (range: 3-52 yr) As part of initial management or salvage therapyGKSRSMedian 3 cc Median margin dose 15 Gy9 patientsMedian 28 mo after GKSRS Tumor control 68%
Boëthius et al[50]2002 (1978-1997)PA19Mean age 10.6 yr (range: 2-60 yr)Adjuvant therapyGKSRSMedian 2.2 cc Median margin dose 10 Gy2 patientsMedian radiological follow-up 4.7 yrTumor control 94.7%
Somaza et al[51]1996 (1990-1993)PA9Mean age 8.6 yr (range: 4-17 yr)Adjuvant or salvage therapyGKSRSMean tumor diameter 16 mm Median margin dose 15 Gy2 patientsMedian 19 moTumor control 100%